Published 2 days ago • loading... • Updated 17 hours ago

HIV self-tests to be available at pharmacies

Summary by NZ Herald

From RNZ New Zealanders who want to know if they are HIV positive can now access home tests from the pharmacy for the first time. The test costs $39.99 and...

10 Articles

All

Left

Center

Right

NZ Herald

Center

HIV self-tests to be available at pharmacies

From RNZ New Zealanders who want to know if they are HIV positive can now access home tests from the pharmacy for the first time. The test costs $39.99 and...

17 hours ago·Auckland, New Zealand

Read Full Article

RNZ

Center

'It's timely now' - HIV self-tests to be available at pharmacies

The test costs $39.99.

20 hours ago·New Zealand

Read Full Article

Science Daily

Reposted by

Medical Xpress

Center

Novel point-of-care technology delivers accurate HIV results in minutes

The technology described uses a nanomechanical platform and tiny cantilevers to detect multiple HIV antigens at high sensitivity in a matter of minutes. These silicon cantilevers are cheap and easy to mass produce and can be readily equipped with a digital readout. Built into a solar-powered device, this technology could be taken to hard-to-reach parts of the world where early detection remains a challenge to deliver fast interventions to vulner…

2 days ago·United States

Read Full Article

Otago Daily Times

HIV self-tests to be available at NZ pharmacies

HIV testing will soon be able to be done at home in New Zealand. File photo: Getty Images New Zealanders who want to know if they are HIV positive can now access home tests from the pharmacy for the first time.

20 hours ago·Otago, New Zealand

Read Full Article

ScienceDirect

Nanomechanical systems for the rapid detection of HIV-1 p24 antigen

Early detection of HIV is crucial for reducing transmission and ensuring timely initiation of antiretroviral therapy (ART), significantly improving pa…

20 hours ago·Amsterdam, Netherlands

Read Full Article

SaportaReport

Emory research connected to second patient in sustained remission of HIV - SaportaReport

Emory University’s pioneering work with a class of small molecules known as JAK (janus kinase) inhibitors continues to generate interest into how HIV might be cured after a second patient who received the treatment was declared to be in long-term remission. The use of JAK inhibitors against HIV began with a ground-breaking discovery led by Christina Gavegnano, an assistant professor with appointments in the Emory School of Medicine and the Emory…

1 day ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year